[Federal Register Volume 87, Number 53 (Friday, March 18, 2022)]
[Notices]
[Pages 15432-15433]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-05798]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Docket No. CDC-2022-0037; NIOSH 278]


Board of Scientific Counselors, National Institute for 
Occupational Safety and Health (BSC, NIOSH)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting and request for comment.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following virtual meeting of the Board of Scientific 
Counselors, National Institute for Occupational Safety and Health (BSC, 
NIOSH). This is a virtual meeting and open to the public, limited only 
by web conference lines (500 web conference lines are available). Time 
will be available for public comment.

DATES: The meeting will be held on April 20, 2022, from 10:00 a.m.-3:00 
p.m., EDT.
    Written comments must be submitted by April 13, 2022.

ADDRESSES: This is a virtual meeting. You may submit comments, 
identified by Docket No. CDC-2022-0037; NIOSH-278 by mail. CDC does not 
accept comments by email.
    <bullet> Federal eRulemaking Portal: https://www.regulations.gov. 
Follow the instructions for submitting comments.
    <bullet> Mail: Docket number CDC-2021-0037; NIOSH-278, c/o Sherri 
Diana, NIOSH Docket Office, National Institute

[[Page 15433]]

for Occupational Safety and Health, 1090 Tusculum Avenue, MS C-34, 
Cincinnati, Ohio 45226.
    Instructions: All submissions received must include the Agency name 
and Docket Number. Written public comments received by April 13, 2022, 
will be provided to the BSC prior to the meeting. Docket number CDC-
2022-0037; and NIOSH-278 will close April 13, 2022.

FOR FURTHER INFORMATION CONTACT: Emily J.K. Novicki, M.A., M.P.H., 
Executive Secretary, BSC, NIOSH, CDC, 1600 Clifton Avenue, MS V24-4, 
Atlanta, Georgia 30329-4027, Telephone: (404) 498-2581, Email: 
<a href="/cdn-cgi/l/email-protection#3b5e55544d525850527b585f58155c544d"><span class="__cf_email__" data-cfemail="73161d1c051a10181a331017105d141c05">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION:
    Purpose: The Secretary, the Assistant Secretary for Health, and by 
delegation the Director, Centers for Disease Control and Prevention, 
are authorized under Sections 301 and 308 of the Public Health Service 
Act to conduct directly or by grants or contracts, research, 
experiments, and demonstrations relating to occupational safety and 
health and to mine health. The Board of Scientific Counselors provides 
guidance to the Director, National Institute for Occupational Safety 
and Health on research and prevention programs. Specifically, the Board 
provides guidance on the Institute's research activities related to 
developing and evaluating hypotheses, systematically documenting 
findings and disseminating results. The Board evaluates the degree to 
which the activities of the National Institute for Occupational Safety 
and Health: (1) Conform to appropriate scientific standards, (2) 
address current, relevant needs, and (3) produce intended results.
    Matters to be Considered: The agenda for the meeting addresses the 
evolving national landscape for respiratory protection and occupational 
robotics research. Agenda items are subject to change as priorities 
dictate.
    An agenda is also posted on the NIOSH website (http://www.cdc.gov/niosh/bsc/).
    Meeting Information: It is open to the public, limited only by web 
conference lines (500 web conference lines are available). If you wish 
to attend, please register at the NIOSH website http://www.cdc.gov/niosh/bsc/ or call (404-498-2581) no later than April 13, 2022.

Public Participation

    Comments received are part of the public record and are subject to 
public disclosure. Do not include any information in your comment or 
supporting materials that you consider confidential or inappropriate 
for public disclosure. If you include your name, contact information, 
or other information that identifies you in the body of your comments, 
that information will be on public display. CDC will review all 
submissions and may choose to redact, or withhold, submissions 
containing private or proprietary information such as Social Security 
numbers, medical information, inappropriate language, or duplicate/near 
duplicate examples of a mass-mail campaign. CDC will carefully consider 
all comments submitted into the docket. CDC does not accept comment by 
email.
    Oral Public Comment: The public is welcome to participate during 
the public comment period, from 1:00 p.m. to 1:15 p.m., EDT, April 20, 
2022. Please note that the public comment period ends at the time 
indicated above. Each commenter will be provided up to five minutes for 
comment. A limited number of time slots are available and will be 
assigned on a first come-first served basis. Members of the public who 
wish to address the BSC NIOSH are requested to contact the Executive 
Secretary for scheduling purposes (see FOR FUTHER INFORMATION above).
    Written Public Comment: Written comments will also be accepted from 
those unable to attend the public session per the instructions provided 
in the addresses section above. Written comments received in advance of 
the meeting will be included in the official record of the meeting. 
Written comments received by April 13, 2022, will be provided to the 
BSC prior to the meeting.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-05798 Filed 3-17-22; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>